Orasure Technologies Inc (OSUR): Douglas A Michels , President & CEO of Orasure Technologies Inc sold 25,000 shares on Sep 26, 2016. The Insider selling transaction was reported by the company on Sep 28, 2016 to the Securities and Exchange Commission. The shares were sold at $8.22 per share for a total value of $205,525.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Aug 31, 2016, Jack E Jerrett (SVP & General Counsel) sold 68,686 shares at $8.52 per share price.On Aug 31, 2016, Charles W Patrick (director) sold 26,308 shares at $8.25 per share price.
OraSure Technologies: On Tuesday, Sep 27, 2016 heightened volatility was witnessed in OraSure Technologies which led to swings in the share price. The shares opened for trading at $8.14 and hit $8.26 on the upside , eventually ending the session at $8.19, with a gain of 0.61% or 0.05 points. The heightened volatility saw the trading volume jump to 8,53,011 shares. The 52-week high of the share price is $9.05 and the company has a market cap of $455 M . The 52-week low of the share price is at $4.39.
OraSure Technologies Inc. (OraSure) is involved in the development manufacture marketing and sale of oral fluid diagnostic products and specimen collection devices and other diagnostic products designed to detect or diagnose critical medical conditions. These products include OraQuick In-Home HIV Test OraQuick ADVANCE OraSure HIV-1 oral specimen collection device OraQuick HCV rapid antibody test Intercept oral fluid drug testing system OraSure QuickFlu Rapid Flu A&B Test and Q.E.D. Saliva Alcohol test. The Company also manufactures and sells a range of cryosurgical products. Through its wholly owned subsidiary DNA Genotek Inc. the Company provides oral fluid sample collection stabilization and preparation products for molecular diagnostic applications.